Special Issue "Prostatectomy: The Current Recommendations for Clinical Practice"

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Nephrology & Urology".

Deadline for manuscript submissions: 20 January 2024 | Viewed by 1246

Special Issue Editors

Department of Surgery, Candiolo Cancer Institute, FPO-IRCCS, Strada Provinciale 142, km 3, 95 10060, Candiolo, Turin, Italy
Interests: prostate cancer; robotics; laparoscopy; new technology; 3D; uro-oncology
Special Issues, Collections and Topics in MDPI journals
Division of Urology, Department of Oncology, University of Turin, Turin, Italy
Interests: robotics; prostate cancer; kidney cancer; new technology; 3D; augmented reality

Special Issue Information

Dear Colleagues,

Prostate cancer is the first malignancy in men, and radical prostatectomy represents the standard treatment for localized disease. In recent years, different technological and technical innovations have been developed, starting from the advent of robotic systems in the early 2000 until the lastly introduced single port platform. In parallel, new imaging modalities can help both for staging purposes and intraoperative navigation, such as the availability of real-time overlapping of 3D models in an augmented reality setting. Finally, surgical indication has also been reconsidered under the light of new technologies such as the PSMA-PET, and new horizons have been opened, such as for the treatment of oligometastatic patients. In this Special Issue, we invite authors to submit papers (clinical studies or reviews) on radical prostatectomy, including the description of surgical techniques or approaches and the introduction of new imaging modalities and new technologies.

Dr. Enrico Checcucci
Prof. Dr. Francesco Porpiglia
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • prostate cancer
  • robotics
  • single port
  • augmented reality
  • confocal microscopy

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

Article
Machine-Learning-Based Tool to Predict Target Prostate Biopsy Outcomes: An Internal Validation Study
J. Clin. Med. 2023, 12(13), 4358; https://doi.org/10.3390/jcm12134358 - 28 Jun 2023
Viewed by 498
Abstract
The aim of this study is to present a personalized predictive model (PPM) with a machine learning (ML) system that is able to identify and classify patients with suspected prostate cancer (PCa) following mpMRI. We extracted all the patients who underwent fusion biopsy [...] Read more.
The aim of this study is to present a personalized predictive model (PPM) with a machine learning (ML) system that is able to identify and classify patients with suspected prostate cancer (PCa) following mpMRI. We extracted all the patients who underwent fusion biopsy (FB) from March 2014 to December 2019, while patients from August 2020 to April 2021 were included as a validation set. The proposed system was based on the following four ML methods: a fuzzy inference system (FIS), the support vector machine (SVM), k-nearest neighbors (KNN), and self-organizing maps (SOMs). Then, a system based on fuzzy logic (FL) + SVM was compared with logistic regression (LR) and standard diagnostic tools. A total of 1448 patients were included in the training set, while 181 patients were included in the validation set. The area under the curve (AUC) of the proposed FIS + SVM model was comparable with the LR model but outperformed the other diagnostic tools. The FIS + SVM model demonstrated the best performance, in terms of negative predictive value (NPV), on the training set (78.5%); moreover, it outperformed the LR in terms of specificity (92.1% vs. 83%). Considering the validation set, our model outperformed the other methods in terms of NPV (60.7%), sensitivity (90.8%), and accuracy (69.1%). In conclusion, we successfully developed and validated a PPM tool using the FIS + SVM model to calculate the probability of PCa prior to a prostate FB, avoiding useless ones in 15% of the cases. Full article
(This article belongs to the Special Issue Prostatectomy: The Current Recommendations for Clinical Practice)
Show Figures

Figure 1

Review

Jump to: Research

Review
A Systematic Review of New Imaging Technologies for Robotic Prostatectomy: From Molecular Imaging to Augmented Reality
J. Clin. Med. 2023, 12(16), 5425; https://doi.org/10.3390/jcm12165425 - 21 Aug 2023
Viewed by 490
Abstract
New imaging technologies play a pivotal role in the current management of patients with prostate cancer. Robotic assisted radical prostatectomy (RARP) is a standard of care for localized disease and through the already imaging-based console subject of research towards combinations of imaging technologies [...] Read more.
New imaging technologies play a pivotal role in the current management of patients with prostate cancer. Robotic assisted radical prostatectomy (RARP) is a standard of care for localized disease and through the already imaging-based console subject of research towards combinations of imaging technologies and RARP as well as their impact on surgical outcomes. Therefore, we aimed to provide a comprehensive analysis of the currently available literature for new imaging technologies for RARP. On 24 January 2023, we performed a systematic review of the current literature on Pubmed, Scopus and Web of Science according to the PRISMA guidelines and Oxford levels of evidence. A total of 46 studies were identified of which 19 studies focus on imaging of the primary tumor, 12 studies on the intraoperative tumor detection of lymph nodes and 15 studies on the training of surgeons. While the feasibility of combined approaches using new imaging technologies including MRI, PSMA-PET CT or intraoperatively applied radioactive and fluorescent dyes has been demonstrated, the prospective confirmation of improvements in surgical outcomes is currently ongoing. Full article
(This article belongs to the Special Issue Prostatectomy: The Current Recommendations for Clinical Practice)
Show Figures

Figure 1

Back to TopTop